Effects of White Wine vs. Tea Intake During and an Alcoholic Digestive Following a High Fat, High Calorie Cheese Fondue Meal on Gastric Emptying and Abdominal Symptoms in Healthy Volunteers
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Tradition holds that the intake of different drinks with a meal has an important influence on the digestion of food and postprandial symptoms such as fullness, bloating and satiety; however this assumption have never been subjected to controlled study
A classic example is the Swiss cheese fondue. The intake of white wine, tea and cherry schnapps (Kirsch) are often attributed either positive or negative effects on the gastrointestinal tract.
In this study the effect of white wine vs. tea intake during and an alcoholic digestive following a high fat, high calorie Swiss fondue meal on gastric emptying and visceral perception will be investigated using a randomized, controlled study design.
The fondue will be labeled with non-radioactive 13C octanoate for assessment of gastric emptying by breath-test.
| Condition | Intervention | Phase |
|---|---|---|
|
Healthy Participants |
Dietary Supplement: Ingestion of white wine vs. tea during and an alco |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Health Services Research |
- Effect of white wine vs. tea on gastric emptying [ Time Frame: 4 hours ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 12 |
| Study Start Date: | August 2009 |
| Study Completion Date: | October 2009 |
| Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |
-
Dietary Supplement: Ingestion of white wine vs. tea during and an alco
Eligibility| Ages Eligible for Study: | 19 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion criteria: • able to communicate well with the investigators and provide written consent
• Body Mass Index: 19-30 kg/m2
Exclusion criteria: • physical co-morbidity requiring active treatment
- psychiatric (DSM IV) disorders limiting the ability to comply with study
- use of medications influencing upper GI motility
- evidence of current drug or alcohol abuse
- history of gastrointestinal disease or surgery except appendicectomy or hernia repair
Contacts and Locations
More Information
No publications provided by University of Zurich
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Dr. Mark Fox, University of Zurich |
| ClinicalTrials.gov Identifier: | NCT00943696 History of Changes |
| Other Study ID Numbers: | Fonduestudie_EKGs |
| Study First Received: | July 20, 2009 |
| Last Updated: | June 24, 2010 |
| Health Authority: | Switzerland: UZurich |
ClinicalTrials.gov processed this record on May 21, 2013